We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Eureka Genomics Launches 16S Metagenomics Next Generation Sequencing & Bioinformatics Services

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Dr. Edgar's significant contributions to the analysis of sequence data include the development of MUSCLE (one of the most popular programs in biology with >5,600 citations to date), UCHIME (the most sensitive and efficient algorithm published to date for detection of chimeric amplicons in 16S metagenomics) and OTUPIPE (a new method for creating OTUs; used in the Human Microbiome Project).

The Eureka Genomics 16S metagenomics service leverages the high throughput of Illumina sequencing with EG's ability to massively multiplex samples, to parse massively multiplexed samples and to perform quality filtering, clustering and classification of this large amount of data. EG's 16S metagenomics service utilizes the most up-to-date analytical solutions, is flexible, and serves the needs of a broad range of clients, from the microbiologist with a few samples, to the scientist with a thousand samples, to the biologist needing ultra-deep 16S metagenomics analysis on individual samples.

"Eureka Genomics is excited to offer a quantum leap in quality 16S metagenomics. Clients can send extracted DNA, a sequencing-ready library or sequence data. This service fulfills real needs of the biological community, will enable discoveries through population/comparative analysis, and is complementary to EG's shotgun metagenomic service," says Adrian Costa, National Sales Manager for Eureka Genomics.

"Eureka Genomics empowers its customers with all the tools needed to conceptualize, perform, and interpret data from the innovative studies in human microbiome, biofuels, industrial enzymes, microbial genomics, bioremediation, crop protection, comparative population biology, microbial oil recovery, disease-associated pathogen discovery and others," added Costa.